Objetivo
Organ transplantation has emerged as the “gold standard” therapy for end-stage organ failure. Incomplete control of chronic allograft injury but also the adverse effects of long-term immunosuppression (IS) continue to challenge the long-term success of transplantation. The paradigm is shifting from increasing “net”-IS by novel drugs to the concept of minimizing long-term IS as early as possible. However, data were almost completely generated by “trial-and-error” observational studies. It suggests an unmet need to stratify transplant (Tx) patients regarding their immunological responsiveness to the allograft and their respective individual need of IS. The central focus of the project is the implementation of biomarker-driven strategies for personalizing IS to improve the long-term outcome and to decrease the adverse effects and costs of chronic IS. This includes 5 innovative investigator-driven biomarker clinical trials designed by the consortium with >1800 (screening) / 1000 (trial) patients. The following issues will be addressed: -targeted complete/partial weaning of standard IS in long-term stable liver and kidney Tx patients identified as “operationally tolerant” by recently developed biomarker panels-prevention of CNI-based standard IS in low-responder kidney Tx recipients by perioperative biomarker-based stratification-shifting high to low-responder kidney Tx patients suitable for early minimisation by the recently explored selective targeting of alloreactive effector/memory T cells -implementing new biomarker candidates supporting personalized IS within the clinical trials-analysing the health-economic impact of biomarker-guided personalized IS -studying the mechanisms behind successful weaning (regulation/effector balance) -disseminating the results and developing commercialisation by partnering with SME/industry. The project will take advantage and exploit recent research findings–Indices of Tolerance (IOT) and RISET but also of other international groups.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2012-INNOVATION-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-FP - Small or medium-scale focused research projectCoordinador
10117 Berlin
Alemania
Ver en el mapa
Participantes (16)
44093 Nantes
Ver en el mapa
OX1 2JD Oxford
Ver en el mapa
WC2R 2LS London
Ver en el mapa
08007 Barcelona
Ver en el mapa
14021 Prague 4
Ver en el mapa
1105AZ Amsterdam
Ver en el mapa
93053 Regensburg
Ver en el mapa
20251 Hamburg
Ver en el mapa
12159 Berlin
Ver en el mapa
13009 Marseille
Ver en el mapa
72479 Strassberg
Ver en el mapa
35394 GIESSEN
Ver en el mapa
La participación finalizó
80636 MUNICH
Ver en el mapa
KT16 0RS Chertsey
Ver en el mapa
53100 Siena
Ver en el mapa
1019 GM AMSTERDAM
Ver en el mapa